Table 3.
Factors associated with minoxidil discontinuation
| Factor | Treatment discontinuation | p-Value | |||
|---|---|---|---|---|---|
| No (N = 51) | Yes (N = 345) | ||||
| n | % | N | % | ||
| Sex | |||||
| Male | 22 | 16.4 | 112 | 83.6 | |
| Female | 33 | 12.4 | 233 | 87.6 | 0.271 |
| Age | |||||
| ≤ 32 years | 26 | 11.1 | 208 | 88.9 | |
| > 32 years | 29 | 17.5 | 137 | 82.5 | 0.069 |
| Other treatments for androgenetic alopecia | |||||
| No | 43 | 13.2 | 282 | 86.8 | |
| Yes | 12 | 16.0 | 63 | 84.0 | 0.530 |
| Minoxidil duration | |||||
| ≤ 1 month | 6 | 7.2 | 77 | 92.8 | |
| 2–3 months | 3 | 3.0 | 96 | 97.0 | |
| 4–6 months | 11 | 13.1 | 73 | 86.9 | |
| 6–12 months | 9 | 14.5 | 53 | 85.5 | |
| > 1 year | 22 | 45.8 | 26 | 54.2 | |
| Not documented | 4 | 16.7 | 20 | 83.3 | < 0.001* |
| Self-reported outcomes | |||||
| Improvement | 27 | 30.7 | 61 | 69.3 | |
| Stabilization | 14 | 35.9 | 25 | 64.1 | |
| Baby hair | 2 | 11.1 | 16 | 88.9 | |
| No improvement | 12 | 4.7 | 243 | 95.3 | < 0.001* |
| Complications | |||||
| No | 40 | 24.2 | 125 | 75.8 | |
| Yes | 15 | 6.4 | 220 | 93.6 | < 0.001* |
| No. of complications | |||||
| 0 | 40 | 24.2 | 125 | 75.8 | |
| 1 | 11 | 6.6 | 155 | 93.4 | |
| 2+ | 4 | 5.8 | 65 | 94.2 | < 0.001* |
*Statistically significant result (p < 0.05)